Healthcare costs of direct oral anticoagulants among Medicare patients with nonvalvular atrial fibrillation and multimorbidity

The effectiveness of selexipag in pulmonary arterial hypertension patients with and without associated connective tissue disease comorbidity in United States

Abstract RATIONALE: Patients diagnosed with pulmonary arterial hypertension (PAH) and connective tissue disorders (CTD) have a poorer prognosis than those diagnosed with PAH not associated with CTD. In the pivotal GRIPHON study, the efficacy and safety of selexipag in...